Skip to content

Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection

Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01197027
Enrollment
28
Registered
2010-09-09
Start date
2010-02-28
Completion date
2012-04-30
Last updated
2022-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute HIV Infection

Brief summary

The purpose of this study is to evaluate the acceptability and feasibility of an enhanced, individual-level counseling intervention for individuals in the acute and early phase of HIV infection aimed at reducing risk behaviors.

Interventions

Standard HIV counseling

Sponsors

HIV Prevention Trials Network
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be enrolled in CHAVI 001 Note: The inclusion and

Exclusion criteria

for CHAVI 001 are provided below. The criteria will not be reassessed prior to enrollment in HPTN 062. * Inclusion Criteria from CHAVI 001 * Men and women aged ≥ 18 years at the time of screening. * Able and willing to provide adequate information for locator purposes. * Hemoglobin \> 10.0 g/dL. * Willing to receive HIV test results. * Not intending to relocate out of the area for the duration of study participation and does not have a job or other obligations that may require long absences from the area. * Has acute HIV infection. (See Section 2.3 for definition).

Design outcomes

Primary

MeasureTime frame
Proportion of participants in the experimental arm who receive the first four intervention sessions between enrollment and week 2 visitWeek 2

Secondary

MeasureTime frame
Number of self-reported unprotected sex acts6 months

Countries

Malawi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026